Related Experiment Video

Updated: Aug 15, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Experimental therapy using interferon-gamma and anti-Fas antibody against oral malignant melanoma cells

Takahiko Kamei1, Madoka Inui, Minoru Nakase

  • 1Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Mie University, Japan. t-kamei@clin.medic.mie-u.ac.jp

Melanoma Research
|September 24, 2005
PubMed

Insights

Combination therapy with interferon-gamma (IFN-gamma) and anti-Fas antibody (CH-11) demonstrated a significant anti-tumor effect in oral malignant melanoma models. This approach enhances Fas-mediated apoptosis, offering a promising strategy for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The Fas/FasL system is crucial for chemotherapy-induced apoptosis.
  • Interferon-gamma (IFN-gamma) increases Fas expression in oral malignant melanoma cells.
  • Previous in vitro studies showed synergistic effects of IFN-gamma and anti-Fas antibody (CH-11).

Purpose of the Study:

  • To investigate the in vivo anti-tumor efficacy of anti-Fas antibody therapy against oral malignant melanoma (MMN9 cells).
  • To evaluate the combined therapeutic effect of IFN-gamma and CH-11 in a mouse model.
  • To analyze the mechanism of action, focusing on Fas-mediated apoptosis.

Main Methods:

  • Experimental therapy using anti-Fas antibody (CH-11) in a mouse model with MMN9 cells.
  • Combination treatment with IFN-gamma and CH-11.
  • Histological examination of tumor tissue using terminal deoxynucleotidyl transferase-mediated nick end labelling (TUNEL) and immunostaining for Fas expression.
  • In vitro assessment of apoptosis inhibition using a caspase inhibitor (benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone).

Main Results:

  • Combined IFN-gamma and CH-11 administration resulted in a 53.8% increase in anti-tumor effect compared to controls (P=0.0018).
  • Histological analysis showed increased Fas expression and positive TUNEL staining in the combined treatment group.
  • Caspase inhibition significantly reduced IFN-gamma/CH-11-induced apoptosis in vitro, suggesting a caspase-dependent pathway.
  • Bcl-2 cleavage was not observed, indicating a link between caspase activation and Bcl-2 cleavage in MMN9 cells.

Conclusions:

  • Combination therapy with IFN-gamma and anti-Fas antibody (CH-11) is effective against oral malignant melanoma in vivo.
  • The therapeutic efficacy is mediated through the modulation of Fas-mediated apoptosis.
  • The findings suggest a caspase-dependent apoptotic pathway involved in this combination therapy.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...